Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05722171Early Phase 1Unknown
Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia
PrincipalinvestigatorStart date: 2022-12-27
NCT05170568Phase 1Unknown
PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
PrincipalinvestigatorStart date: 2021-12-01

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

He Huang, doctor

Zhejiang University

Related
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia

Worked with same sponsors:

PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Similarity Score15%

Jorge E Cortes, MD

Augusta University

Related
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

Peihua Lu, MD/PHD

HeiBei YanDa Ludaopei hospital

Related
2 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

wenting Hu

Shanghai children's medical center

Related
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

Olu Lawson

SystImmune Inc.

Related
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

Gail Roboz, Dr

Weill Medical College of Cornell University

Related
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

Daniel Pollyea, MD

University of Colorado, Denver

Related
5 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

Liping Dou, Dr.

Chinese PLA General Hospital

Related
1 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

Daihong Liu, doctor

Chinese PLA General Hospital

Related
8 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia

Worked with same sponsors:

Peking University People's HospitalThe First Affiliated Hospital of Zhengzhou University
Similarity Score15%

zhiguo Long

Shanghai Pudong Hospital

Related
3 trials

Shared therapeutic areas:

Relapsed/Refractory Acute Myeloid Leukemia
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05722171Early Phase 1PrincipalInvestigator

Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia
Unknown
NCT05170568Phase 1PrincipalInvestigator

PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies

CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Unknown

All 2 trials loaded